Department of Internal Medicine, Seoul National University Bundang Hospital, Seoungnam, Gyeonggi-do, Korea.
Int J Cancer. 2013 Nov;133(9):2034-42. doi: 10.1002/ijc.28219. Epub 2013 Jun 12.
Changes of DNA methylation in gastric mucosae after eradication of Helicobacter pylori have not been clarified yet. From this background, we investigated time course of DNA methylation following H. pylori eradication in 221 successfully H. pylori eradicated subjects with endoscopic follow-up at least for 6 months, including 114 controls, 53 subjects with gastric dysplasia and 54 patients with early gastric cancer. All dysplasia and gastric cancer patients underwent endoscopic resection at the time of enrollment. The methylation levels in LOX, APC and MOS genes from noncancerous gastric mucosae using quantitative methylation-specific PCR, as well as the histologic findings of gastric mucosae, were compared before and after eradication. Average follow-up duration was 26.0 months (range: 6 to 76 months). H. pylori eradication decreased methylation levels in LOX (p-value for slope < 0.001) but not in APC. In MOS, decrease of its methylation level following H. pylori eradication was significant among controls without intestinal metaplasia (IM) (p-value for slope < 0.05); however, it was not observed among patients with IM or those with dysplasia or gastric cancer. After H. pylori eradication, methylation level in MOS persistently increased in patients with dysplasia or gastric cancer (p < 0.01). In conclusion, H. pylori eradication decreases aberrant DNA methylation with gene-specific manner. Methylation level in MOS is associated with IM and may be used as a surrogate marker for gastric cancer risk, regardless of H. pylori eradication history.
幽门螺杆菌根除后胃黏膜 DNA 甲基化的变化尚不清楚。基于这一背景,我们对 221 例成功根除幽门螺杆菌且内镜随访至少 6 个月的患者(包括 114 例对照、53 例胃黏膜异型增生和 54 例早期胃癌患者)进行了研究,以探究幽门螺杆菌根除后 DNA 甲基化的时程变化。所有异型增生和胃癌患者均在入组时接受了内镜切除术。采用定量甲基化特异性 PCR 检测非癌性胃黏膜中 LOX、APC 和 MOS 基因的甲基化水平,并比较了根除前后胃黏膜的组织学发现。平均随访时间为 26.0 个月(范围:6 至 76 个月)。幽门螺杆菌根除降低了 LOX 的甲基化水平(斜率 p 值<0.001),但 APC 没有。在 MOS 中,无肠化生(IM)的对照组患者根除幽门螺杆菌后其甲基化水平下降(斜率 p 值<0.05);然而,在 IM 患者、异型增生或胃癌患者中则未观察到这种情况。幽门螺杆菌根除后,异型增生或胃癌患者的 MOS 甲基化水平持续升高(p<0.01)。综上所述,幽门螺杆菌根除以基因特异性的方式降低异常 DNA 甲基化。MOS 的甲基化水平与 IM 相关,可作为胃癌风险的替代标志物,而与幽门螺杆菌根除史无关。